BiotechTube
Home/Sichuan Biokin Pharmaceutical/Not Available in Source
NA

Not Available in Source

Chief Executive Officer

Sichuan Biokin Pharmaceutical

Roles

Chief Executive OfficeratSichuan Biokin Pharmaceutical
Chief Scientific OfficeratSichuan Biokin Pharmaceutical
Chief Financial OfficeratSichuan Biokin Pharmaceutical

Therapeutic Areas

OncologyImmunology

Sichuan Biokin Pharmaceutical Pipeline

DrugIndicationPhase
BK-001 (Anti-PD-1 mAb)Non-Small Cell Lung Cancer, Hodgkin's LymphomaNDA Submitted
BK-020 (VEGF Inhibitor Biosimilar)Colorectal Cancer, NSCLC, Age-related Macular DegenerationLaunched
BK-105 (Anti-TNFα mAb Biosimilar)Rheumatoid Arthritis, Psoriasis, Ankylosing SpondylitisLaunched
BK-302 (Anti-IL-17A mAb)Psoriasis, Psoriatic ArthritisPhase III
BK-450 (Anti-HER2 mAb Biosimilar)HER2+ Breast Cancer, Gastric CancerPhase III
BK-508 (Dual-specific Antibody)Advanced Solid TumorsPhase I/II
BK-600 (Anti-IL-4Rα mAb)Atopic Dermatitis, AsthmaPhase II